pDCs have a weak antigen-presenting capacity but can participate in the tumor immune response in other ways, such as by secreting IFN-I (39) and cross-priming naïve CD8+ T-cells by transferring antigens to cDCs via exosomes (40). The gene discussed is CD8A; the disease is neoplasm.